Remember ME - You Me and Dementia

Showing posts with label Genetics. Show all posts
Showing posts with label Genetics. Show all posts

June 27, 2011

UK: Lean gene 'linked to heart risk'

LONDON, England / BBC News / Health / June 27, 2010

Genes that result in a slender figure have been linked to heart disease and type-two diabetes, conditions normally associated with being overweight.

A study suggests variants of the IRS1 gene reduce fat under the skin, but not the more dangerous visceral fat around organs such as the heart and liver.

 Slim people can still have heart risk, researchers warn

The Medical Research Council study, published in Nature Genetics, examined the genes of more than 76,000 people.

The link between the genetic variants and the conditions was stronger in men.

Skinny risk
The lead researcher, Dr Ruth Loos, said: "We've uncovered a truly fascinating genetic story and when we found the effect of this gene we were very intrigued.

"It is not only overweight individuals who can be predisposed for these metabolic diseases, and lean individuals shouldn't make assumptions that they are healthy based on their appearance."

Dr Iain Frame, director of research at the charity Diabetes UK, said the study could "shed light on why 20% of people with type-two diabetes have the condition despite being a healthy weight".

"It is also a clear message that people who appear slim shouldn't be complacent about their health," he added.
British Heart Foundation associate medical director Prof Jeremy Pearson said: "These results reinforce the idea that it is not just how fat you are, but where you lay down fat that's particularly important for heart risk.
"Fat stored internally is worse for you than fat stored under the skin.

"However, they don't detract from the fact that being overweight is bad for your heart health, so we should still try to stay lean and fit."

BBC © 2011 
______________________________________________________  
Credit: Reports and photographs are property of owners of intellectual rights.  
Seniors World Chronicle, a not-for-profit, serves to chronicle and widen their reach.

October 18, 2010

USA: Seven Siblings - Who Will Get Alzheimer's?

. NEW YORK, NY / ABC News / Health / October 18, 2010

Seven Siblings: Who Will Get Alzheimer's?

After Caring for Their Elderly Mother, Brothers and Sisters Enter Study to Help Find a Genetic Marker

By SUSAN DONALDSON JAMES

During the 11 years that Margaret Albus lived with Alzheimer's disease, the worst moment came in the middle of one night, when she called out to her daughter, panic-stricken: "I just want to know who I am."

Watch video

"I am almost crying now," said Becky Albus, a 53-year-old optician who was looking after her elderly parents that weekend. "I would have done anything not to let her be scared."

Margaret Albus died on December 31, 2009, at the age of 86. But she had mentally slipped away a decade before. She had seven children.

"It's the disease of the long goodbye. It's a perfect description," said another daughter, Elaine Albus, 51, a team leader for a Minnesota business improvement company.

"The fear in her eyes, it's hard to watch over and over again," she said. "There's nothing you can do about the terror but say, 'Mom, it's all right. We'll take care of you.'"

All seven of Margaret's middle-aged children -- four sisters and three brothers -- are at increased risk for developing Alzheimer's disease.

A decade ago, they volunteered to be part of a study at the University of Wisconsin to find genetic markers for the disease that today affects 5 million Americans.


The goal of the study, the largest of its kind, is to identify people in middle age and follow them in the hopes of learning how the disease develops.

Scientists hope that if they can find markers to predict eventual onset, they can develop early interventions.

"There is no cure, we can only save it off," said Dr. Mark A. Sager, director of the Wisconsin Alzheimer's Institute, who heads the research.

"This is a terrible disease and to have a parent or anyone in the family [with Alzheimer's] leaves an indelible mark," he said. "The loss of identity and loss of personality -- we have an organ called the brain that is who we are."

The disease affects so many people that when the study was announced 10 years ago, the institute got 600 phone calls in the first 24 hours.

"We never had to recruit, that's how much interest there was in the study," he said. "And people have traveled large distances to be a part of it."

Now, the study includes 1,500 participants with a mean age of 53, including all seven of the Albus siblings. The hardest part has been finding those who don't have a family history -- and a compelling reason to participate -- for a comparison group, according to Sager.

Risk factors for the disease include increasing age and abnormalities in the apolipoprotein E gene (APOE), which is on chromosome 19 and has three different alleles, or alternative purposed, like those for eye and hair color.

One -- the e4 allele -- is associated with increased risk. Not all who have this gene will go on to get the disease, but they are more susceptible

Elaine Albus and her mother, who died of Alzheimer?s disease last year, are shown in happier times. (Courtesy of Elaine and Becky Albus)

APOE was first recognized for its importance in lipoprotein metabolism and cardiovascular disease, but has more recently been studied for its role in the onset of Alzheimer's disease. About 44 percent of the study participants have APOE abnormalities. They have more than double the risk of the general population, 15 to 20 percent of whom have that gene sequencing.

"The disease is more prevalent in women because they live longer," said Sager.

Disease onset is typically in the late 70s and early 80s. By age 85, 30 to 50 percent of adults have symptoms.

Margaret Albus, a homemaker, raised her large family in the small Wisconsin town of Lady Smith, where her husband Roger ran a business that made conveyers for farm equipment.

But when she reached 75, her memory began to fail. After tests revealed she had Alzheimer's disease, the siblings called a family conference.

"All of us kids came from wherever we lived and sat around the table," remembers Elaine. "We all knew there was something wrong with Mom, but to have it confirmed is awful. On the ride back I was with one of my sisters who also live in the Twin Cities and we cried. There is nothing you can really do."


"Mom just sat in the meeting, kind of like it wasn't about her," said Elaine. "She never really remembered getting the diagnosis."

Her family meant everything to her, but eventually, Margaret Albus didn't even remember who her children were.

"Once in a while she would say, 'Elaine,' and I would look at her. Wow, where did that come from?" said Elaine. "Sometimes she would know you and sometimes she wouldn't. It's really hard to see your parents -- someone to talk to about what's going on in your life -- and then they're not there anymore."

The Albus children know that one day this may be their fate. Some of them have already bought long-term care insurance and they talk about looking into nursing homes and assisted care facilities after reaching retirement.

"I kind of feel like it's for sure, out of seven of us, a couple of us are going to get it," said Elaine. "So you have to keep telling yourself it could be you, and be prepared for it."

But they say they keep their sense of humor.

"In my family it's become a natural thing to do," she said. "Every time someone forgets, we say, 'It's starting already.' We say we will get rooms next to each other. It's a little bit of denial, joking with each other."

Family Had Resources to Deal with Alzheimer's

"I fully expect that I will be in a facility," said Elaine, who is single and doesn't have children. "I want my nieces and nephews to get me in early enough. My one big fear is being one of those cat ladies, and the social services come in, and I am living in garbage with animals all over the place."

The entire Albus Family is shown in this file photo. Since their mother's diagnosis with Alzheimer's disease, all seven siblings have participated in a study to find genetic markers that might help doctors stave off its onset. (Courtesy of Elaine and Becky Albus)

The Albus family had both the money and manpower to look after their mother, so care giving was not as stressful as it is for some families.

At first, Roger Albus looked after his wife, but soon, the siblings set up a weekend schedule to help give their father some relief.

"Six years ago, Dad was totally stressed out," said Elaine.

Kathy Cronick, 48 and the youngest, lives in Lady Smith. She checked in on her parents each day, handling the shopping and doctors' visits.

The others, who lived across Minnesota and Wisconsin, two or three hours away, set up a rotation, staying with their parents on weekends.

"I cannot imagine how a smaller family does it with not so many people to pitch in," she said. "It would be much more stressful."

Cronick said Alzheimer's disease is "always in the back of my mind.

"But there's nothing you can do about it and there are no cures, so what happens, happens. I just hope I forget quickly," she said. "I know it was really scary to see my Mom, but I don't dwell on it."

The siblings said they were lucky because their mother was "an easy person and always good natured," which is not always the case with Alzheimer's patients.

"She was unhappy when we took the car keys away, then we told her we were going to get the car to get fixed and she accepted that," said Elaine Albus. "I hear others have a personality change or become totally violent."

"As Mom would say, 'We are blessed.' And as awful as it was, it could have been so much worse," she said.

But things started to get more difficult.

"Eventually my dad started not sleeping well and worried about Mom getting up," said Elaine. "We convinced him to get overnight help so he could get a solid night's sleep and they could hear when she wandered."


They blocked off stairs and put locks high on doors so their mother couldn't open them. Her husband put wind chimes on the bedroom door so that he could hear it opening and closing.

Until their mother got pneumonia and died in the hospital, the family was able to keep her at home, where their father, now nearly 94, still lives on his own. "He's pretty sharp for his age," said Elaine.


"Right until the end, she knew Dad was someone important to her, though she didn't know who he was," said Becky Albus. "But we feel really blessed we didn't have to put her in a nursing home."

Some of the Albus siblings are happier about the poking and prodding of the Alzheimer's study than others.

Researchers took fasting blood samples, weight and measurements. Every two or three years, they are subjected to periodic mental tests, repeating word lists and solving math problems.

The follow-up continues "until they lose their funding or make some discovery," according to Elaine.

The study will compare its data, is looking at factors that might contribute to the onset of Alzheimer's, such as lifestyle choices and diet. Exercise is thought to be protective. They keep track of monitor cognition, years of education, biochemical parameters in the blood and rising levels of homocysteine, an amino acid associated with dementia.

"There is good data to suggest that midlife obesity, high levels of cholesterol in midlife and a host of other things that occur in midlife that increase the risk 20 or 30 years later," said study director Sager.

Participants are not told the results of all these tests, and the institute has filed a certificate of confidentiality with the National Institutes of Health, so that personal data can never be released and have an impact on insurance decisions.

At information sessions, Sager and his colleagues tell families like the Albuses, "There's no guarantee [the study] will help you one bit, but we hope your children will be the beneficiary of the research."

"At first, I naively thought this will save Mom -- they'd figure something out," said Becky Albus. "But it was quickly obvious that wasn't going to happen. And it probably won't happen for us either."

But the study has been "remarkable," said Elaine Albus. "I think we are all doing this because we loved our Mom. Mom can't benefit, but we might be able to benefit my 13 nieces and nephews."

"Its' very frightening to know that as the baby boomers age, there will be so many who get Alzheimer's," said her sister, Kathy. "We just wanted to do what we could to help."

Copyright © 2010 ABC News Internet Ventures.

May 25, 2010

UK: The genetics dilemma facing doctors

.
LONDON, England / The Guardian / Life & Style / Health & Wellbeing / May 25, 2010 

The genetics dilemma facing doctors

A patient has an inherited illness which could put family members at risk –
but what if they're kept in the dark?

By Denis Campbell
 
'It's genetics that are forcing me to do this," says Shirley McQueen. After seeing 10 close female relatives, including her mother and older sister, die of breast cancer, the 47-year-old has made a drastic decision. She is going to have both her breasts removed.

Shirley McQueen . . . 'I don't mind losing my breasts if it means I stay free of breast cancer. I've been on Death Row since I was five and I want to get off.'
Photograph: Christian Sinibaldi for the Guardian

"From an early age I have accepted that I am going to die, and I have prepared my son and daughter for that," says McQueen. Given the sheer number of her female relatives to get the disease, and the fact none survived it, Dr James MacKay, a genetic oncologist who is treating McQueen, believes there is a particularly aggressive breast cancer gene within her family which will ultimately trigger it inside her too.

"I don't mind losing my breasts if it means that I stay free of breast cancer," McQueen says forcefully. "I've been on Death Row since I was five and I want to get off it. I want to be around for my grandchildren."

Recent years have brought breakthroughs in knowledge about the genetic basis of conditions, such as obesity and cancers and there has been a rapid increase in the availability of NHS and over the counter tests to identify or rule out certain diseases. Ophthalmology company Optegra has launched a genetic home testing kit in the last few weeks, for example, to assess the risk of developing Age-Related Macular Degeneration, a leading cause of blindness, while the BCtect blood test claims to allow early detection of breast cancer.

"Genetics is becoming more of an issue for patients," says Jane O'Brien of the General Medical Council, which regulates doctors. But genetic conditions throw up difficult practical and ethical issues for doctors. "You may, in the course of inquiries about one patient, find out things about other people that can have a profound impact on their health. Instead of it just being Patient A, it's about his children and siblings too," explains O'Brien. But should doctors pass on to these others the news that there is a risk, possibly a high risk? Conditions such as Huntington's disease, which attacks the central nervous system, or Marfan syndrome, which affects the connective tissue that keeps the body together, are the result of a single gene mutation which may be inherited from a parent and so may cause disease in the patient's siblings, and possibly the wider family too.

Last autumn the GMC revised its guidance to doctors on confidentiality, and introduced a section on genetic and other shared information – situations when a diagnosis in one patient might point to the certainty or likelihood of a blood relative having the same condition. Most patients, like McQueen, will agree to their relatives being told about their condition, so family members can have preventative treatment, get screened to assess their risk, or prepare themselves for the reality of becoming ill. "However, a patient might refuse to consent to the disclosure of information that would benefit others, for example where family relationships have broken down, or if their natural children have been adopted," says the GMC's guidance. So what should a doctor do?

"In these circumstances, disclosure might still be justified in the public interest," states the GMC, adding, "If a patient refuses consent to disclosure, you will need to balance your duty to make the care of your patient your first concern against your duty to help protect the other person from serious harm." O'Brien says that the dilemma is no different to when a patient who is a bus driver has a serious alcohol problem or a patient admits to abusing children. The public interest demands disclosure.

Such dilemmas are increasing, says Dr Emma Cuzner, a medico-legal adviser with the Medical Defence Union (MDU), which helps doctors who have been accused of misconduct. Between 2000 and 2004 the MDU had 11 inquiries about confidentiality in patients found to have a genetic abnormality. Between 2005 and 2009 they had 22.

"These are not large numbers but I think it shows that this is a growing area of concern for doctors and one that is likely to continue as the number of genetic tests available increases," adds Cuzner. "These cases are delicate, and emotionally charged and can involve an awful dilemma, for the patient and the doctor." In 17 of those 33 cases doctors were seeking advice about whether or not to disclose information about a patient's genetic status that might affect a relative – the other 16 were patients asking for their genetic condition to be omitted from medical forms, usually for insurance applications, or be removed from their medical records altogether.

The MDU says a scenario when a doctor would be justified in breaking confidentiality could be if a patient was found to have an inherited form of colon cancer. If a father has it, each of his children has a 50% chance of getting it and siblings also have a 50% risk, while a nephew or niece would also be at risk. Once the relatives knew they could get screened and then – if necessary – have surgery to minimise their risk. If the patient did not want anyone else to be told the doctor could inform them. In this case a doctor could break the patient's confidentiality, but should first take advice, from a geneticist or a defence organisation such as the MDU, and think carefully, as the decision may be challenged.

It's a tricky dilemma, but, as Cuzner says, one that is becoming more urgent. "As tests become more sophisticated, and more and more conditions are found to have a genetic basis, the medical profession will be confronting these situations more and more in the future." [rc]

© Guardian News and Media Limited 2010

May 6, 2010

NEW ZEALAND: 'Every day is a bonus'

.
AUCKLAND, New Zealand / Northshore Times / May 6, 2010

By Sarah Coddington - North Shore Times

SIMON LEIGH is living on "bonus time"
but he is still determined to make the most of every day.

LAST DAYS: Simon Leigh has emphysema and has not been given long to live but North Shore Hospice is helping him make the best of his days.  Pic: Ben Watson

The Beach Haven resident was given 12 months to live back in September 2008 and jokes he is on bonus time.

Mr Leigh, 46, has emphysema that is caused by a genetic deficiency of a protein called alpha-1 antitrypsin. The protein protects the body from an enzyme that causes infection and without it body tissues, such as the lungs, can come under attack.

The onset of emphysema started back in 1998 when he experienced a severe shortness of breath attack while stripping wallpaper at home.

Mr Leigh ran his own IT consultancy business but is now confined to bed and permanently attached to an oxygen machine. He admits to being a smoker for 20 years.

Mr Leigh says he's "one decent dose of pneumonia away from the end".

He has separated from his wife Michelle but they remain on good terms and he has a flat attached to her home so he can spend precious time with their sons Dylan and Kieran.

Dylan, 12, often visits his father and they build Lego together and chat. Kieran, 15, comes down each night to check everything is okay before he goes to bed.

"They have lived with it most of their lives – they have always had a sick dad.

"They are normal kids which is good. I wouldn't want them to be upset but I don't know if they realise how much it will affect them when I'm gone," he says.

Helpers come in every day to help with daily routines like showering and tidying the house.

North Shore Hospice volunteers and staff have also been a great help, he says.

In particular he is grateful to his hospice counsellor and family support team leader Maxine Pye who has helped him and has family come to terms with his fate.

"I have had more than 10 years to come to terms with it. Sometimes you're in denial, sometimes you're angry, then accepting and then you switch back to denial," says Mr Leigh.

Once every few months he goes to hospice so his progress and medication can be monitored.

It comforts Mr Leigh to know hospice will be there for his family when he dies.  [rc]

© 2010 Fairfax New Zealand Limited

April 15, 2010

UK: Babies with three parents may be key to preventing genetic disorders

. LONDON, England / The Times / News / Science / Genetics / April 15, 2010 Babies with three parents are just years away, the scientists say. Posed by models/Pat Doyle/Corbis By Mark Henderson, Science Editor Babies with three biological parents could be conceived within three years after research that could stop children from inheriting severe diseases. Scientists at Newcastle University have grown human embryos after merging DNA from two fertilised eggs, with a technique that could soon be used to prevent serious genetic disorders that affect 100 children in Britain a year. The aim is to correct faulty “cellular batteries” — mitochondria — which can cause fatal heart, liver, neurological and muscle conditions, by replacing them with healthy ones from a donated embryo. A child would inherit genetic material from three parents. The mother and father would supply 99.8 per cent of its DNA, with a small amount from another woman, the mitochondrial donor. Doug Turnbull, who led the research, said that it could potentially help families at risk from mitochondrial diseases to have healthy children in as little as three years, although follow-up studies are still needed. Related Links Scientist's plea to Royal Institution rebels How to be a new dad – aged 52 Sacked baroness ‘holds scientists to ransom’ There are regulatory barriers. In Britain it is illegal to place embryos created this way into a womb, but the Health Secretary can rescind the ban without legislating. Alison Murdoch, another leader of the team, said: “I don’t think we have the information yet to go to the Secretary of State. But we think the time is right to enter discussions about what information will be required for the Secretary of State to make that provision.” One in 200 children is born each year with genetic mutations in the mitochondria — energy-producing structures in cells inherited from the egg. The effects are usually mild, but in 1 in 6,500 people incurable disease is caused. In the Newcastle technique, embryos are created by IVF, using the mother’s eggs and her partner’s sperm. After fertilisation two “pronuclei” from the egg and sperm, containing the parents’ DNA, are removed. These are injected into a donated embryo with healthy mitochondria, from which the pronuclei have been removed. In the experiments, reported in Nature, the scientists showed that this method was practical, using faulty embryos left over after IVF and donated for research. About 8 per cent of the modified embryos grew normally to the blastocyst stage of 100 to 150 cells, indicating that they could be viable. The scientists expect better results with normal embryos, rather than abnormal ones discarded after IVF. They are seeking to conduct such research. Professor Turnbull said: “What we’ve done is like changing the battery on a laptop. None of the information on the hard drive has been changed. A child would have correctly functioning mitochondria but in every other respect would get all their genetic information from their father and mother.This technique could allow us to prevent the diseases occurring.” The research was funded by the Wellcome Trust, Medical Research Council and Muscular Dystrophy Campaign. [rc] Copyright 2010 Times Newspapers Ltd.

April 7, 2010

WORLD: Pharma seeks genetic clues to healthy ageing

. LONDON, England / Reuters / Healthcare / April 6, 2010 * Centenarian genes probed for secrets of health, long life * Hunt for drugs to fight wide spectrum of age-related ills By Kate Kelland, Health and Science Correspondent They may be a little wrinkly, and there may not be many of them, but centenarians are the fastest growing demographic in the developed world. Scientists believe people who live to 100 years or more hold valuable secrets in their genes that can reveal targets for medicines to tackle a wide range of age-related diseases, as well as improving longevity itself. "If you make it to 100, you must have had good health and a good life -- otherwise you wouldn't be at the tail end of the age distribution curve," Kaare Christensen of the Danish Ageing Research Centre told Reuters in an interview. "So basically, we're trying to figure out how they do it." Of course, genes are not the whole story: experts believe genetic factors account for a only fraction of longevity. Other factors like a healthy lifestyle, good diet and safe environment combine to play a role in determining when we die. Yet so-called "longevity genes" certainly exist, and their importance grows the longer a person lives, so identifying them and finding out what they do to fight off killer diseases is a hot area of research. With lifespans already increasing at a breathtaking rate -- an average of three months is being added to life expectancy every year at the moment -- scientists stress that a "magic pill" to help people live ever longer is not what anyone should be seeking. Instead the aim is known as "compression of morbidity" -- improving the health of rapidly ageing populations and squeezing to a minimum the amount of time at the end of their lives when they are sick, in pain, or dependent. "None of us, probably, wants another five years in a nursing home," said Linda Partridge, director of University College London's Institute of Healthy Ageing. "But an additional five years without any particular health problems would be another matter." LONGEVITY GENE POOL One thing is sure: the pool of people to work with is growing fast. There are around 450,000 centenarians in the world today and experts estimate that thanks to ageing baby-boomers, there could be a million across the world by 2030. Genetic science and technology is developing rapidly too, allowing scientists to scan the genes of the super-old in search of the secrets of long life -- and drugs to mimic them are starting to appear. "The drug companies have got lots of patents out on some of these targets," said Partridge. "Nothing has actually emerged yet, but they are clearly working on them." Until recently, only one candidate had shown any promise as a potential "longevity gene". It is known as APOE. On the one hand, its variants have been linked with an increased risk of heart disease and of developing the brain-wasting disease, Alzheimer's. On the other, it is associated with a greater chance of a longer, healthier life. Scientists have found that a particular variant known as APOE4, which gives carriers a higher risk of developing Alzheimer's and heart disease, is about 50 percent less common in centenarians than in younger people, suggesting that those without it are more likely to live longer. Other "longevity gene" candidates are now starting to emerge, including one called FOXO3A and another called humanin, both of which have links to the body's insulin pathways. With them comes more evidence that genes associated with long life are also linked to decreased risk of major killers like heart disease, Alzheimer's and diabetes. Nir Barzilai of the Albert Einstein College of Medicine at Yeshiva University in New York has been conducting studies with a group of several hundred centenarians in the United States to see if he can find gene patterns that can be chemically copied. 102 year old Rhea Tauber with Professor Nir Barzilai. Photo credit: BBC Health "We are assuming that the 100 year-olds are enriched with longevity genes," he said in an interview. "And when you find genes, you discover the pathway, and then you can try to modulate the pathway with drugs." As well as with the humanin gene, his team has been working with variations of a gene known as cholesteryl ester transfer protein, or CETP, which they have linked to long life, good heart health, a reduced risk of cognitive decline with age, and a smaller chance of developing Alzheimer's disease. Drug companies are already targeting the CETP gene with an eye to helping prevent heart disease by upping so-called "good" or HDL cholesterol. The U.S. drugmaker Merck & Co, for example, has a CETP drug in late-stage clinical trials to test its effectiveness in raising good cholesterol. But Barzilai thinks it may turn out to do much more than that: "We believe that once this drug is out it could be the first drug to be used as an anti-ageing drug," he said. Swiss pharmaceutical company Roche also has a CETP drug, called dalcetrapib, in late-stage clinical trials in partnership with Japan Tobacco, in which it sees great potential. LONGER, HEALTHIER LIVES? The emerging link between long life and disease resistance has already been seen in animal experiments. Last week, British scientists found in experiments with labaoratory worms that the DAF-16 gene, similar to FOXO genes in humans, is linked to ageing and immunity. And several studies have shown that when scientists successfully target the underlying ageing process to make an animal live longer, they also protect them against ageing-related diseases. Resveratrol, a drug being developed by Britain's GlaxoSmithKline and based on a compound found in red wine, has been shown in studies on mice to give them longer and healthier lives. And the antibiotic rapamycin, sold under the brand name Rapamune by Pfizer and designed to suppress the immune system in transplant patients, has also been shown to slow age-related disease and extend life-span in mice. "These things are all very interwoven in each other," said Christensen. Partridge also sees this as a sign that some medicines now on the horizon may be bigger hitters than previously thought. "What it shows very clearly is there is an underlying ageing process which acts as the major risk factor for ageing-related diseases, and if you can somehow ameliorate its effects, then the animals become relatively disease-free," she said. "They (the drugs) may be being developed specifically for dementia, or cancer, or some specific age-related disease, but the biological research is telling us that they're probably going to turn out to have surprisingly broad-spectrum effects." [rc] Editing by Sara Ledwith © Copyright 2010 Thomson Reuters

March 17, 2010

FINLAND: Leena Peltonen-Palotie, Human Geneticist, Dies of Cancer

. PHILADELPHIA, Pennsylvania / The Scientist / March 17, 2010 By Bob Grant Finnish-born geneticist and physician Leena Peltonen-Palotie, who uncovered numerous genetic mutations behind various human diseases, passed away in Finland last week at the age of 57. Peltonen-Palotie helped establish the human genetics department at the Geffen School of Medicine at the University of California, Los Angeles, held appointments at the Broad Institute of MIT and Harvard in Boston, and served as the head of human genetics at the Wellcome Trust Sanger Institute. She succumbed to cancer on March 11. "She was a world-class geneticist who was known throughout the world for her clinically relevant work in human genetics," said Gerald Levey, former dean of UCLA's Geffen School of Medicine who hired Peltonen-Palotie to lead the newly created human genetics department there in the late 1990s. Leena Peltonen-Palotie (1952-2010) Image: Academy of Finland Peltonen-Palotie was a prolific researcher throughout her 37-year career in genetics. Much of her research had its roots in her native Finland -- a country that keeps extensive genealogical and medical records on its genetically isolated citizens -- where she identified 15 genes that play a role in different "Finnish heritage diseases," rare disorders such as Cohen syndrome and Meckel syndrome that are more prevalent in Finland than anywhere else in the world. Peltonen-Palotie also tackled the genetics behind more common diseases, such as schizophrenia, lactose intolerance, obesity, and multiple sclerosis. In total, she published more than 500 scientific papers over her career, with three of her papers cited more than 500 times each, according to ISI. Peltonen-Palotie also used what she learned from Finnish genetics to understand other populations, and focused on bringing that knowledge into the clinic, Mark Daly, a geneticist at Massachusetts General Hospital and the Broad Institute who collaborated with Peltonen-Palotie on several projects over the years, told The Scientist. Straddling the line between research and clinician was one of Peltonen-Palotie's hallmarks, agreed Levey. "She and her group were really the quintessential translational researchers," he said. "They were doing high-class science, but they were asking clinical questions. That's why she had such an impact in her genetics research." Peltonen-Palotie also waded into the public discussion on human genetics. "Leena was always at the forefront of the public policy discourse and the ethics discourse," said Daly. "It's extraordinarily rare that someone combines the highest level of scientific excellence, a remarkable dedication to training, and a commitment to public discussion. This is just a trifecta that's unmatched." Obtaining her MD and PhD in Finland, Peltonen-Palotie did a postdoc at Rutgers University in New Jersey, then took a position in Finland's National Public Health Institute. In 1998, she returned to the US to take the reins of the fledgling human genetics department at UCLA's Geffen School of Medicine. Though she only stayed at UCLA until 2002, Peltonen-Palotie left her mark, largely through building what Levey called "a first-class training program and a first-class faculty in a relatively short period of time." Peltonen-Palotie left UCLA for a professorship at the University of Helsinki, then accepted an appointment at the Broad Institute. A position as head of human genetics at the Wellcome Trust Sanger Institute, and more research focusing on disease gene mapping, followed. Peltonen-Palotie's accomplishments in science were matched by her personal warmth and approachability. "She had this very special magnetism that made her able to interact with and attract people," Levey said. "Leena had an amazing intellect, an extraordinary amount of energy. She was just an extraordinary woman -- full of life with a vision of where the field [of human genetics] should go." "She was a tremendously warm, friendly, enthusiastic, and encouraging person," Daly added. "We're going to miss her tremendously." Peltonen-Palotie mentored dozens of young scientists, supervising more than 70 PhD students over the course of her career, according to the Wellcome Trust Sanger Institute. "As outstanding a scientist that she was, she was also deeply committed to developing human genetics as a field," Daly recalled. "I don't know of anyone who trained more PhD students than her, and had those students remain more loyal to her." "What she accomplished will last forever and will be built on," added Levey. "I have no doubt, even though she's gone, that those trainees will carry on her work and accomplish the kinds of things she accomplished. She will live on through all the trainees she mentored." [rc] © 1986-2010 The Scientist

GERMANY: Nobel Prize Winner Opens Genomics Lab at Cologne Research Center

. COLOGNE, Germany / Germany.info / Genetics Research / March 17, 2010 South African biologist Sydney Brenner, a 2002 Nobel Prize winner, opens a laboratory at the Cologne Center for Genomics (CCG) on March 19. Brenner is considered one of the most prolific pioneers in modern molecular biology. He will give the keynote address at the opening of the new laboratory of the CCG. Together with H. Robert Horvitz and John E. Sulston, Brenner won the Nobel Prize for Medicine/Physiology for his pioneering work on genetic regulation of organ development and programmed cell death. The nematode C. elegans was established by Brenner as a model organism. The exploration of its organ and nervous system development was of particular interest. Through the use of this nematode, the first genes essential for programmed cell death could be described. Model organisms and brain research Model organisms play a large role in research conducted by the Cologne Excellence Cluster on Cellular Stress Response in Age-Associated Diseases (CECAD Cologne) and the newly founded Max Planck Institute (MPI) for Biology of Aging. Thus the leading minds working on model organisms - with the appointment of Thorsten Hoppe at CECAD and Adam Antebi at the MPI - are leading this research which builds on the earlier findings of Brenner. Already in the 1960s, Brenner contributed to the clarification of the genetic code. Together with his colleagues, he was one of the first to see the model of the structure of DNA in 1953 and by the 1960s he was contributing to the clarification of the genetic code. In 1974, he was awarded the Royal Medal of the Royal Society. The Cologne Center for Genomics, one of the main players in the Cluster of Excellence for Aging Research at the University and Uniklinik Köln, is a technology center in genomics supported by the natural sciences and medicine faculties. It offers an infrastructure for sequencing and the study of genes in complex diseases. [rc] Related Links: Cologne Center for Genomics CECAD Cologne © Young Germany

February 19, 2010

USA: Want To Live Forever?

. MOFFETT FIELD, California / Singularity Hub / Longevity / February 19, 2010 Want To Live Forever? Better Hope You Have the Right FOXO3A Gene By Aaron Saenz German researchers at the Christian Albrechts University in Kiel recently confirmed that variants of the FOXO3A gene are a common characteristic for many people who live past 100. The CAU team studied 380+ centenarians, more than 600 people in their 90s, and more than 700 60-75 year olds to determine how prevalent these gene variations were. They found that not only were certain FOXO3A variants very common in 90 year olds, they were even more common in 100 year olds, emphasizing the importance of genetics for aging well. The CAU work confirms earlier research performed by J. Wilcox that found FOXO3A variants among Japanese American centenarians. A common gene variant is found in many centenarians. It could explain how some live past 100 despite their lifestyle. Both papers were published in the Proceedings of the National Academy of Sciences (PNAS). CAU has a partner group in France that showed similar results there. Taken together, these studies suggest that FOXO3A may be a global factor for longevity. While none of these teams have worked to extend human life per se, understanding FOXO3A variations may eventually lead to genetic treatments to help us all live past the century mark. The past few decades have seen a growing interest in longevity as medicine continues to advance life expectancy. Groups like the Methuselah Foundation (sponsors of the MPrize) are actively seeking technology to extend lifespans. Yet, understanding aging is not an exact science. We do know that genetics, environmental risks/lifestyle, and strong social bonds are all part of what helps someone live longer. Studies of centenarians, however, have suggested that while genetics don’t seem to make a big difference in the early decades of old age, they have a profound effect determining who makes it into extreme old age. Variants in FOXO3A may be one of the key ingredients that help take a healthy 80 year old, and turn her into a healthy 110 year old. Unfortunately, we can’t know which genes are important without actually understanding how they work to preserve us as we age. It’s important that we make it clear that everyone has a FOXO3A gene. It is the variation in single sections of that gene (single nucleotide polymorphisms) which are important. CAU looked at 16 of these SNPs, while Wilcox studied 3. As we better understand which of these SNPs are key for longevity, you’ll be able to test for them with personal DNA tests or whole genome sequencing. Of course, you probably don’t just want to know if you have great gene variants, you probably also want to be able to exchange your genes for better ones. There have been some promising results from scientists studying how limited genetic manipulation can extend the life of mice. In humans, however, we are likely to seek ways of producing the effects of genetic manipulation without actually splicing our genes. The FOXO3A gene codes for the FOXO3A protein. If we figure out how longevity variants of FOXO3A change the protein (in its form, frequency, etc) we could then produce drugs that replicate that change and give our bodies long life. CAU was able to perform such a (relatively) large study so quickly thanks to the Schleswig Holstein biobank known as Popgen. It has more than 650 samples of centenarian DNA on file. Biobanks store genetic samples for use in scientific studies and are a resource of growing importance. I wonder what other insights we’ll develop in the next few years as biobank data becomes available to more researchers in a variety of fields. Getting older is wonderful if you are still healthy. Genetic research may not only tell us how to increase lifespans, but also how to extend our youth. I’ll be taking a personal DNA test very soon (an article on that is forthcoming) and the CAU research has me excited about what I could learn. Admittedly, I doubt that any SNP detection company is ready to test for these FOXO3A variants yet, but there’s still a ton more to know. Genetics don’t dominate every part of your life but, as this research shows, there are times when they become very important. Learning more about your genes is the first step to taking advantage of (and compensating for) your body’s natural inclinations. I can’t wait. Related Posts: •Disabling a Single Gene Extends Mice Life by 20% •Get Ready To Live Past 100 •3 Genetic Variants Account for 20% of Risk for Alzheimer's •Living past 100 years with anti-aging genes •Will 23andMe Find Which Genes Make You a Life-Long Athlete?[rc] Copyright 2010. Singularity Hub.

February 12, 2010

USA: Ragan is Nebraska's oldest person

. OMAHA, Nebraska / Omaha World-Herald / News / February 12, 2010 By Kevin Cole, World-Herald Staff Writer The mantle of being Nebraska's oldest resident has passed to Mabel Ragan of Albion. Ragan, 109 years and 11 days old as of today, became the state's top centenarian when Leona Gleed died Sunday in a Norfolk nursing home at the age of 109 years, 316 days. Centenarians can credit “good genes” for their longevity, said Dr. L. Stephen Coles of the Gerontology Research Group in Los Angeles. “Good genes are the most important element to living a long life,” Coles said. “Good genes help people escape from heart disease, cancer, diabetes … all manner of diseases that typically cut short our lives.” Advertising The oldest Iowa resident is Neva Morris of Ames. Morris, 114 years and 192 days, was born Aug. 3, 1895. She is believed to be the third-oldest person in the world. E.A. Kral, a retired teacher and researcher who lives in Wilber, Neb., said Leona Gleed was the oldest twin in Nebraska history. Her twin brother, Leo, died in 1990 at age 89. Kral said the twins were born March 28, 1900, near Page, Neb. They were among 11 children born to Edward and Sarah Adams. Leona Adams married rancher Lloyd Gleed on Feb. 14, 1926, at Dakota City. They lived on a ranch west of Chambers, where they farmed and raised three daughters. After her husband died in 1963, Gleed studied library science at Nebraska Wesleyan University in Lincoln. She returned to Holt County in 1966 to live in O'Neill. She moved to Norfolk in 1992. Gleed once told Kral that her secret to longevity was to stay busy and appreciate each day. “Don't miss anything,” she said. “Make every minute count, keep up your activities. That is a good way to get old.” A funeral service for Gleed was held Thursday at the United Methodist Church in Chambers. She is survived by daughters Celesta Cooke of Norfolk, Armetta Prill of Tulsa, Okla., and Doris Covault of Des Moines; 14 grandchildren, 30 great-grandchildren; 31 great-great-grandchildren; and a sister, Etha Walters of Grand Island. Ragan, born Feb. 1, 1901, on a farm near Newman Grove, lives at the Wolf Memorial Good Samaritan Center in Albion. She graduated from Albion High School in 1919. Nebraska's second-oldest living resident is Mabel Holman Holliday, 108, of Nemaha County, born May 6, 1901. She is followed by Rose Koch Portwood, 107, of Jefferson County, born March 5, 1902; Sophie Becker of Boone County, 107, born Dec. 30, 1902; and Eleanor Wrede Nielsen, 107, of Knox County, born Jan. 26, 1903. Becker, like Ragan, lives at the Albion care center. The world's oldest person as of todayis said to be Kama Chinen of Japan, 114 years and 278 days, according to the Los Angeles gerontology group. Mary Ray of Westmoreland, N.H., is the oldest living American at 114 years and 271 days. [rc] Copyright ©2010 Omaha World-Herald

December 24, 2009

USA: Face looking old? Don't blame your genes

. NEW YORK / Reuters Health / December 24, 2009 Don't blame genes for aging facial skin. A new study of twins suggests you can blame those coarse wrinkles, brown or pink spots, and dilated blood vessels on too much time in the sun, smoking, and being overweight. Because twins share genes, but may have different exposures to environmental factors, studying twins allows an, "opportunity to control for genetic susceptibility," Dr. Elma D. Baron, at Case Western Reserve School of Medicine in Cleveland, Ohio, and colleagues explain in the latest issue of Archives of Dermatology. Their analysis of environmental skin-damaging factors in 65 pairs of twins hints that skin aging is related more to environment and lifestyle than genetic factors. But when it comes to skin cancer, the researchers say their findings support previous reports that both environment and genes affect skin cancer risk. Baron's team examined facial skin of 130 twins, 18 to 77 years old, who lived mostly in the northern Midwest and Eastern regions of the U.S. who were attending the Twins Days Festival in Ohio in August 2002. At this time, each of the twins also separately reported how their skin burned or tanned without sunscreen, their weight, and their history of skin cancer, smoking, and alcohol drinking. The study group consisted of 52 fraternal and 10 identical twin pairs, plus 3 pairs who were unsure of their twin status. Identical twins share all of their genes and fraternal twins share only about half. From these data, the researchers noted strong ties, outside of twin status, between smoking, older age, and being overweight, and having facial skin with evidence of environmental damage. By contrast, sunscreen use and drinking alcohol appeared correlated with lesser skin damage. Baron and colleagues say the current findings, which highlight ties between facial aging and potentially avoidable environmental factors -- such as smoking, being overweight, and unprotected overexposure to the sun's damaging rays -- may help motivate people to minimize these risky behaviors. [rc] SOURCE: Archives of Dermatology, December 2009 © Copyright 2009 Thomson Reuters

December 9, 2009

USA: New gene therapy and stem cells save limbs

. BALTIMORE, Maryland / United Press International / Science News / December 9, 2009 U.S. scientists say they have developed an experimental therapy that eliminates blood vessel blockage associated with old age or diabetes. Johns Hopkins University medical researchers say blood vessel blockage can lead to low blood flow, resulting in low oxygen, that can kill cells and tissues. Such blockages can require amputation resulting in loss of limbs. In their new study, the scientists used mice as a model to develop therapies that increase blood flow, improve movement and decrease tissue death and the resulting need for amputation. "In a young, healthy individual, hypoxia -- low oxygen levels -- triggers the body to make factors that help coordinate the growth of new blood vessels. But this process doesn't work as well as we age," said Dr. Gregg Semenza, a professor of pediatrics and genetic medicine. "Now, with the help of gene therapy and stem cells we can help reactivate the body's response to hypoxia and save limbs." He said the study is promising because it shows a combination of gene and cell therapy can improve the outcome in the case of critical limb ischemia associated with aging or diabetes. "And that's critical for bringing such treatment to the clinic," he said. The study was detailed in last week's early online edition of the Proceedings of the National Academy of Sciences. [rc] © 2009 United Press International, Inc.

October 25, 2009

USA: For more than 20 years, he's trying to unlock the secrets to long life

. AMES, Iowa / Ames Tribune / October 25, 2009 Neva Morris, 114, of Ames, talks to her son-in-law Tom Wickersham at Northcrest Community Health Center in Ames. Morris is the fourth-oldest person in the world. By Nirmalendu Majumdar/The Tribune Iowa researcher searches for the recipe for long life By James Pusey, Staff Writer Wrapped in an afghan in the health center wing of Northcrest Community Health Center sits 114-year-old Neva Morris, dozing in a recliner after lunch. “We’ll see how alert she is today, but I can’t promise she’ll be awake,” said 90-year-old Tom Wickersham, Morris’s son-in-law, as he approaches the frail lady and kneels beside her. He leans in close, his face just inches from hers, and speaks in a clear, firm voice. “Hi, grandma. It’s Tom. How are you today?” Morris moves her head slightly, her eyes still closed tight. “Who did you say you were?” she asked. Tom introduces himself again, louder, and Morris noticeably lights up. The two proceed to talk about her lunch, the flowers at her old house and they even sing her favorite song together, “You Are My Sunshine.” All of the activity in the room draws a crowd of several nurses and aids, who are glad to see Morris in such high spirits. For several brief moments in the conversation, Morris opens her eyelids wide, revealing glassy pupils that have seen the world through three centuries. “She’s in good form today,” Wickersham said. “She came here in 1998. Who would have ever thought she’d still be here 10 years later?” Morris is the oldest person in the state of Iowa, and is currently the fourth-oldest person in the world, according to the Gerontology Research Group. There are only about 80 people worldwide who are over the age of 110, a group of people referred to as “supercentenarians.” Peter Martin, an Iowa State University professor of human development and family studies, has been doing research on centenarians and supercentenarians for more than 20 years, trying to unlock the secrets to long life. Martin’s research has identified several factors that play a role in increased longevity, but despite all of his efforts he has not located any one recipe for long life. "It’s more like a recipe book,” Martin said. Some of the major factors contributing to longevity are genetics, environmental support and nutrition, but Martin suspects that one of the most important factors is personality. He said most centenarians have what can be described as robust and resilient personalities. They are generally hard-working and determined people, but they are easy-going when it comes to facing life’s challenges. “They don’t get uptight about things, not anxious,” he said. “There’s probably truth to the saying that you shouldn’t worry yourself to death.” Wickersham said Morris was always very personable and hard-working. He said after her husband died in the 1960s, she assumed responsibility for keeping up the family’s house at 2519 Hoover Ave., in Ames. She lived in that house alone for more than 30 years, until she was well into her nineties, Wickersham said. He said even in her old age she was willing to be adventurous, taking trips to Florida and the Pacific Northwest, and even buying a new Mercury car at the age of 92. “I tried to talk her into getting a lesser horsepower engine, but no sir, she wanted the big one,” Wickersham said, laughing. “And she really liked to drive pretty fast.” Martin said despite having a generally positive outlook on life, centenarians show unusually high levels of depression. However, their depression scores are not due to sadness, Martin said, they are due mostly to fatigue. He said that due to their lack of energy, they find it hard to get motivated to take on new projects. “And who would blame them? If you are 100 you are not going to start a whole lot of new projects today and tomorrow,” Martin said. One of the hardest things for centenarians to cope with is outliving their friends and family members, Martin said. About half of all centenarians have lost at least one of their children, and Martin said many of them feel like their time is way past due. Only Walter, the youngest of Morris’ three children is still living, and he is now 81, Wickersham said. He said Morris has never been one to dwell on her old age, but she’s aware that she’s lived a long time. “On occasion she’s made some comment that maybe she’s lived too long or she wished God would take her, that kind of thing,” Wickersham said. Martin said centenarians are the fastest-growing segment of the U.S. population. Today there are about 70,000 in America, but that number could grow to more than 800,000 by the year 2050. He said it is important that society prepares to for people to live much longer lives – especially in a long-lived state like Iowa, which is home to more centenarians than any state besides South Dakota. “I’m talking with my 20-year-old students in my class about the fact that they should expect to live well into their 90s, if not their 100s,” Martin said. Wickersham said he walks a couple of miles a day, tries to eat right and even though his vision is failing, he’s taken up listening to books on compact disc. As Wickersham ages, he said his mother-in-law’s experience has taught him that aging is all about attitude. “There are some people who can not see the good side of life,” Wickersham said. “I wish I had better vision, but I don’t. You just have to accept that and make the best out of life.” [rc] Copyright © 2009 - Ames Tribune

USA: Gene therapy transforms eyesight of 12 born with rare defect

. LOS ANGELES, California / The Los Angeles Times / Nation / October 25, 2009 Gene therapy transforms eyesight of 12 born with rare defect A single injection in a patient's eye brings 'astounding' results. The findings may offer hope for those with macular degeneration and retinitis pigmentosa. By Thomas H. Maugh II Corey Haas, foreground, has significant improvement in his vision after receiving gene therapy. With him are his parents, Ethan and Nancy, and two research leaders: Dr. Katherine High, left, and Dr. Jean Bennett, right (Daniel Burke Photography) Pennsylvania researchers using gene therapy have made significant improvements in vision in 12 patients with a rare inherited visual defect, a finding that suggests it may be possible to produce similar improvements in a much larger number of patients with retinitis pigmentosa and macular degeneration. The team last year reported success with three adult patients, an achievement that was hailed as a major accomplishment for gene therapy. They have now treated an additional nine patients, including five children, and find that the best results are achieved in the youngest patients, whose defective retinal cells have not had time to die off. The youngest patient, 9-year-old Corey Haas, was considered legally blind before the treatment began. He was confined largely to his house and driveway when playing, had immense difficulties in navigating an obstacle course and required special enlarging equipment for books and help in the classroom. Today, after a single injection of a gene-therapy product in one eye, he rides his bike around the neighborhood, needs no assistance in the classroom, navigates the obstacle course quickly and has even played his first game of softball. The results are "astounding," said Stephen Rose, chief scientific officer of Foundation Fighting Blindness, which supported the work but was not involved directly. "The big take-home message from this is that every individual in the group had improvement . . . and there were no safety issues at all." The study "holds great promise for the future" and "is appealing because of its simplicity," wrote researchers from the Nijmegen Medical Center in the Netherlands in an editorial accompanying the report, which was published online Saturday by the journal Lancet. The 12 patients had Leber's congenital amaurosis, which affects about 3,000 people in the United States and perhaps 130,000 worldwide. Victims are born with severely impaired vision that deteriorates until they are totally blind, usually in childhood or adolescence. There is no treatment. Leber's is a good candidate for gene therapy because most of the visual apparatus is intact, particularly at birth and in childhood. Mistakes in 13 different genes are known to cause it, but all 12 of the patients suffered a defect in a gene called RPE65. This gene produces a vitamin A derivative that is crucial for detecting light. About five children are born each year in the United States with that defect, which was chosen because researchers at the Children's Hospital of Philadelphia and the University of Pennsylvania School of Medicine had cloned the gene, making copies available for use. The study, led by Dr. Katherine A. High, Dr. Albert M. Maguire and Dr. Jean Bennett of those two institutions, enrolled five people in the United States, five from Italy and two from Belgium. Five were children, and the oldest was 44. The good copy of the RPE65 gene was inserted into a defanged version of a human adenovirus. The engineered virus then invaded retinal cells and inserted the gene into the cells' DNA. Maguire used a long, thin needle to insert the preparation into the retina of the worst eye in each of the patients. Within two weeks, the treated eyes began to become more sensitive to light, and within a few more weeks, vision began to improve. The younger the patients were, the better they responded. That was expected, Bennett said, because similar results had been observed in dogs and rodents. By both objective and subjective measures, vision improved for all the patients. They were able to navigate obstacle courses, read eye charts and perform most of the tasks of daily living. The improvement has now persisted for as long as two years. The children who were treated "are now able to walk and play just like any normally sighted child," Maguire said. Bennett noted that the oldest patient in the trial, a mother, had not been able to walk down the street to meet her children at school. "Now she can. She also achieved her primary goal, which was to see her daughter hit a home run." There are clear limitations to the study. The patients' vision was not corrected to normal because of the damage that had already been done to the retina, and only one eye was treated. "The big elephant in the room is: Can you treat the other eye?" Rose said. The foundation will put more funding into the research "to make sure that if you go back and treat the other eye, it won't ablate the positive results in the first eye due to an immune reaction or something else." Researchers also have not optimized the dosage of the adenovirus used to carry the gene into the eye. Those issues will be studied in Phase 2, a larger clinical trial that they hope to begin soon. Meanwhile, the team has begun treating some patients at the University of Iowa. Researchers also hope they will be able to translate the results to other congenital conditions using different genes. Leber's is one form of retinitis pigmentosa, which affects an estimated 100,000 Americans. The findings might be applicable to macular degeneration, which affects an estimated 1.25 million Americans and is the major cause of visual impairment in the elderly. [rc] Thomas H. Maugh II E-mail: thomas.maugh@latimes.com Copyright © 2009, The Los Angeles Times

October 23, 2009

TIBET: 130,500 urban Tibetans have medical insurance

. BEIJING, China / People.com / October 23, 2009 To date, 130,500 urban Tibetan people were covered by the basic medical insurance for urban residents. The annual medical subsidy for urban Tibetan residents has increased from 80 to 120 yuan. To encourage hospital deliver, urban pregnant women enjoying from the basic medical insurance can get a one hundred percent reimbursement in fund of giving birth in hospital. Nearly 1,000 clerks from Tibet's banking sector sing and dance in Lhasa last month. Photo: Xinhua Under the medical insurance, advancement payment for first hospitalization has drop to 100, 200 and 400 yuan respectively in hospitals under first, second and third levels. [rc] Source: China Tibet Information Center Copyright by People's Daily Online

October 21, 2009

WORLD: Growing Life Spans Pose Social, Ethical and Economic Dilemmas

. HARTFORD, Connecticut / Hartford Courant / Health / October 21, 2009 Lessons in Longevity: Growing Life Spans Pose Social, Ethical and Economic Dilemmas This year, the number of pensioners in the United Kingdom exceeded the number of minors for the first time in history. That's remarkable in its own right, but the real "population explosion" has been among the oldest of the old -- the centenarians. In fact, this is the fastest-growing demographic in much of the developed world. And their ranks are set to swell even further, thanks to the aging baby-boomer generation: By 2030, there will be about a million centenarians worldwide. These trends raise social, ethical and economic dilemmas. Are medical advances artificially prolonging life with little regard for the quality of that life? Old age brings an increased risk of chronic disease, disability and dementia, and if growing numbers of elderly people become dependent on state or familial support, society faces skyrocketing costs and commitments. This is the dark cloud outside the silver lining of increasing longevity. Yet researchers who study the oldest old have made a surprising discovery that presents a less bleak vision of the future than many anticipate. Illustration courtesy: Longevity Forum / Photodisc/ Getty Images It's becoming clear that people who break through the 90-plus barrier represent a physical elite, markedly different from the elderly who typically die younger than them. Far from gaining a longer burden of disability, their extra years are often healthy ones. They have a remarkable ability to live through, delay or entirely escape a host of diseases that kill off most of their peers. Supercentenarians -- people aged 110 or over -- are even better examples of aging gracefully. "As a demographic group, they basically didn't exist in the 1970s or '80s," says Craig Willcox of the Okinawa Centenarian Study in Japan. "They have some sort of genetic booster rocket and they seem to be functioning better for longer periods of time than centenarians." The average supercentenarian had freely gone about their daily life until the age of 105 or so, some five to 10 years longer even than centenarians, who are themselves the physical equivalent of people eight to 10 years their junior. This isn't just good news for the oldest old and for society in general; it also provides clues about how more of us might achieve a long and healthy old age. One of the most comprehensive studies comes from Denmark. In 1998, Kaare Christensen at the University of Southern Denmark, Odense, exploited the country's exemplary registries to contact every single one of the 3,600 people born in 1905 who was still alive. Assessing their health over the subsequent decade, he found that the proportion of people who managed to remain independent throughout was constantly around one-third of the total: each individual risked becoming more infirm, but the unhealthiest ones passed away at earlier ages, leaving the strongest behind. In 2005, only 166 of the people in Christensen's sample were alive, but one-third of those were still entirely self-sufficient (Proceedings of the National Academy of Sciences). This is good news from both personal and societal perspectives, for it means that exceptional longevity does not necessarily lead to exceptional levels of disability. Christensen's optimistic findings are echoed in studies all over the world. In the U.S., almost all of the 700-plus people recruited to the New England Centenarian Study (NECS) since it began in 1994 had lived independently until the age of 90, and 40 percent of supercentenarians in the study could still look after themselves. In the UK, Carol Brayne at the University of Cambridge studied 958 people aged over 90 and found that only one-quarter of them were living in institutions or nursing homes. Likewise, research in China reveals that before their deaths, centenarians and nonagenarians spend fewer days ill and bedridden than younger elderly groups, though the end comes quickly when it finally comes. DISTINCTIVE MINDS Of course, people can live independently without being entirely healthy, and it is true that most centenarians suffer from some sort of ailment. These range from osteoarthritis -- which is almost universal and often omitted from studies -- to simple loneliness. Neurodegenerative diseases are common too, with around 70 to 85 percent of centenarians suffering from some form of dementia. But dementia in this group follows a different pattern to the general population. It's more likely to be vascular dementia or rare neurodegenerative conditions such as Pick's disease or Lewy body disease. Alzheimer's disease, the most common form of dementia, is relatively rare among centenarians yet, intriguingly, autopsies reveal that the brains of the oldest old, who had shown no outward sign of dementia, are sometimes riddled with the lesions associated with Alzheimer's disease. The basis of this resilience to Alzheimer's is largely unknown. The simple fact is that many people who become centenarians seem able to tolerate damage that would significantly harm less robust individuals, and although many suffer from dementia as death draws near, most remain mentally agile well into their 90s. Not all of the oldest old survive by delaying illness or disability, though many soldier through it. Jessica Evert of Ohio State University-Columbus examined the medical histories of over 400 centenarians (The Journals of Gerontology). She found that those who achieve extreme longevity tend to fall into three categories. About 40 percent were "delayers," who avoided chronic diseases until after the age of 80. This "compression of morbidity," where chronic illness and disability are squeezed into ever-shorter periods at the end of life, is a recent trend among ageing populations. Another 40 percent were "survivors," who suffered from chronic diseases before the age of 80 but lived longer to tell the tale. The final 20 percent were "escapers," who hit their century with no sign of the most common chronic diseases, including heart disease, cancer, diabetes, hypertension and stroke. Intriguingly, one-third of male centenarians were in this category, compared with only 15 percent of women. So what are the secrets of a long and healthy life? Gerontologists point to four key factors: diet, exercise, "psycho-spiritual" and social, so anyone aiming for a century should not underestimate the power of lifestyle, despite the odd centenarian who proudly claims to have smoked 60 cigarettes a day for decades. Thomas Perls, who heads the NECS, believes that up to 70 percent of longevity is due to non-genetic factors (New Scientist). Nevertheless, many people who live well into old age do tend to have another advantage: an inherited genetic pass.
Take a close relative of a centenarian and you can put good money on their chances of living a long life. Among Americans born in 1900, brothers of centenarians were 17 times as likely to reach a century as their peers, and sisters, eight times. The New England study reveals that the children of centenarians are less than one-third as likely to die of cancer as the general population, and less than one-sixth as likely to die of heart disease. Further evidence of a genetic link comes from longevity hotspots. Okinawa, Japan, is the front runner. At 58 centenarians per 100,000 people (and rising), it has the world's highest proportion in this age group -- more than five times the level of some developed countries. Like other hotspots, including Sardinia and Iceland, Okinawa is a relatively isolated island community, which leads to higher levels of inbreeding and a clustering of genetic variants. While such genetic similarity usually has detrimental effects, in these hotspots it seems to have united and maintained genetic variants that predispose people to a long life. Of course, members of isolated communities or families usually share a particular environment too, but this alone cannot explain clusters of longevity. Gerontologists have found that the influence of environmental factors such as wealth or education on lifespan fades as we age, while that of genes increases. By comparing 10,000 pairs of Scandinavian twins, Christensen found that genes only start exerting a strong influence on our lifespan after the age of 60. Before then, both identical and non-identical twins have largely independent odds of reaching a given age. Beyond 60, however, the odds of one twin reaching a given age are greatly increased if their co-twin has done so, especially if the twins are identical (Human Genetics). This makes the "centenarian genome" a key resource for identifying "longevity genes," an invaluable step in understanding the physiological processes underlying long lives. Such genes have been found in abundance in other organisms -- including over 70 in the worm Caenorhabditis elegans. Unfortunately, it's a different story in humans. While many candidate genes have been suggested to affect lifespan, very few have been consistently verified in multiple populations. Until recently, the only exception was ApoE , and in particular a variant of this gene known as e4 , which bestows carriers with a much higher than average risk of developing Alzheimer's and heart disease. Across the world, this unfortunate version of ApoE is about half as common in centenarians as in younger adults. Last year, a second promising candidate emerged -- a variant of a gene called FOXO3A . At the University of Hawaii, a team led by Bradley Willcox, Craig's identical twin, found that people who carried two copies of a particular form of the gene were almost three times as likely to make it to 100 than those without the variation, and also tended to start their journey into old age with better health and lower levels of stroke, heart disease and cancer (Proceedings of the National Academy of Sciences). "There are so many false positives in this field that FOXO3A is very exciting," says Bradley Willcox. FOXO3A is involved in several signaling pathways that are conserved across animal species. It controls the insulin/IGF-1 pathway, which influences how our bodies process food. It also controls genes that protect cells from highly reactive oxygen radicals - molecules often thought to drive human ageing through the cumulative damage they wreak on DNA. FOXO3A could even protect against cancer by encouraging apoptosis, whereby compromised cells commit suicide. The variant of FOXO3A associated with longevity is much more prevalent in 100-year-olds even than in 95-year-olds, which clearly demonstrates the value of studying the centenarian genome.
So far, the search for longevity genes in humans has been extremely difficult, but prospects brighten as genomic technologies become faster and there are more centenarians to study. Only a lucky few win the genetic lottery of longevity, but if we understand what sets them apart, we may be able to make the rest of us more like them by using lifestyle or therapeutic interventions to manipulate physiological pathways. Such medical advances will not only extend our lives, but also help us remain healthy and independent for as long as possible. Ed Yong is a science writer based in London, England and is member of the Health Information team of Cancer Research UK. ============================================================== TWO PATHS TO 100 The two sexes fare very differently in the longevity stakes. There are far more female centenarians than male ones, but men who do make it past 100 tend to be more physically robust and mentally sharper. The reasons behind this are unclear. It may be simply that the female body is better able to tolerate chronic illnesses and disabilities as it ages. However, natural advantage cannot be the whole story as female centenarians are more likely than their male peers to have ridden to 100 on the back of healthy lifestyles. "For all the major health hazards, women take better care of themselves," says Craig Willcox of Okinawa International University in Japan, who works on the Okinawa Centenarian Study. "They smoke less, drink less alcohol and are less likely to die of violent causes, accidents and suicides. They also go to their physician more." Men, meanwhile, have the double disadvantage of being both more prone to risky behaviours throughout their lives and more likely to succumb to chronic illnesses as they age. This means that men who do make it to their century must depend more on genetic trump cards to see them through. ========================================================================== DYING OF OLD AGE
"There is one, and only one, cause of death at older ages. And that is old age." So said Leonard Hayflick, one of the most influential gerontologists of all time. But dying of old age isn't just a case of peacefully losing the will to live -- it is an accumulation of diseases and injuries different to those that tend to kill people at younger ages. For a start, the oldest old have very low rates of chronic diseases such as cancer, heart disease and stroke. The trend is particularly apparent for cancer. The odds of developing it increase sharply as people age, but they fall from the age of 84, and plummet from 90 onwards. Only 4 percent of centenarians die of cancer, compared with 40 percent of people that die in their 50s and 60s. Many centenarians even manage to ward off chronic diseases after indulging in a lifetime of serious health risks. Many people in the New England Centenarian Study experienced a century free of cancer or heart disease despite smoking as many as 60 cigarettes a day for 50 years. The same story applies to people from Japan's longevity hotspot, Okinawa, where around half of the local supercentenarians had a history of smoking and one-third were regular alcohol drinkers. These people may well have genes that protect them from the dangers of carcinogens or the random mutations that crop up naturally when cells divide. So what does kill off the oldest old? Pneumonia is the biggest culprit, with other respiratory infections, accidents and intestinal problems trailing behind. "Dying of old age involves total systems failure," says Craig Willcox of the Okinawa Centenarian Study in Japan. "Centenarians avoid age-associated diseases, but you see a lot of systemic wear and tear. Almost all of them have had some problems with cataracts, they can't hear very well and have osteoarthritis. Our most recently deceased centenarian in Okinawa caught a cold and died in her sleep."
[rc] Copyright © 2009, Tribune Media Services